Partial functional hypothalamo-pituitary-adrenal inertia with bleaching agents in Senegal;Freinage hypothalamo-hypophyso-surrénalien lié à l'usage de cosmétiques dépigmentants au Sénégal

Bulletin de la Societe de Pathologie Exotique

Volumn 94, Issue 3, 2001, Pages 249-252

  Perret, J L ^a   Sane, M ^a   Gning, S ^a   Ba, K ^a   Rohou, G ^a  

^a HÔPITAL PRINCIPAL DE DAKAR   (Senegal)

Author keywords

Adverse effect; Bleaching agent; Glucocorticoid; Senegal; Sub Saharan Africa

Indexed keywords

CORTICOSTEROID; COSMETIC; DIAGNOSTIC AGENT; HYDROCORTISONE; TETRACOSACTIDE;

ABSORPTION; ADRENAL GLAND; ARTICLE; BLOOD; DRUG EFFECT; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; KINETICS; METABOLISM; SENEGAL; SKIN; SKIN PIGMENTATION;

ABSORPTION; ADRENAL CORTEX HORMONES; ADRENAL GLANDS; COSMETICS; COSYNTROPIN; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; KINETICS; SENEGAL; SKIN; SKIN PIGMENTATION;

EID: 0035433584     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. AGWU JC, SPOUDEAS H, HINDMARCH PC, PRINGLE PJ & BROOK CG - Test of adrenal insufficiency. Arch Dis Child, 1999, 80, 330-333.
2. BROWN ES & SUPPES T - Mood symptoms during corticosteroid therapy: a review. Harv Rev Psychiatry, 1998, 5, 239-246.
3. CISNEROS JR & MURRAY KM - Corticosteroids in tuberculosis. Ann Pharmacother, 1996, 30, 1298-1303.
4. DARMON P, DADOUN F, FRACHEBOIS C, VELUT JG, BOULLU S et al.- On the meaning of low-dose ACTH (1-24) tests to assess functionality of the hypothalamic pituitary adrenal. Eur J Endocrinol 1999, 140, 51-55.
5. DELPEUCH F & MAIRE B - Obésité et développement dans les pays du sud. Méd Trop, 1997, 57, 380-388.
6. DICKSTEIN G, SHECHNER C, NICHOLSON WE, ROSNER I, SHEN-ORR Z et al.- Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab, 1991, 72, 773-778.
7. ELLISON JA, PATEL L, RAY DW, DAVID TJ & CLAYTON PE - Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics. 2000, 105, 794-799.
8. KANE A, BA SA, SARR M, DIOP BI, HANE L et al.- L'HTA au Sénégal: aspects épidémiologiques, cliniques et problèmes de la prise en charge thérapeutique. Dakar Méd, 1995, 40, 157-161.
9. KAWASAKI T, NAKAMAUTA S, UEZONO K, UENO M, ABE I et al.- Plasma cortisol concentrations and circadian rhythm in healthy young Japanese and Caucasians. Nippon Naibunpi Gakkai Zasshi, 1981, 57, 795-805.
10. LONGUI CA, VOTTERA A, HARRIS AG & CHROUSOS GP - Plasma cortisol responses after intramuscular corticotropin 1-24 in healthy men. Metabolism, 1998, 47, 1419-1422.
11. MAHE A, BLANC L, HALNA JM, KEITA S, SANOGO T & BOBIN P - Enquête épidémiologique sur l'utilisation de produits cosmétiques à Bamako. Ann Dermatol Vénéréol, 1993, 120, 190-199.
12. MAHE A, KEITA S & BOBIN P - Complications dermatologiques de l'utilisation cosmétique de produits dépigmentants à Bamako. Ann Dermatol Vénéréol, 1994, 121, 142-146.
13. NYE EJ, GRICE JE, HOCKINGS GI, STRAKOSCH CR, CROSBIE GV et al.- Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal human: low dose, standard high dose, and 8-hour ACTH (1-24) infusion tests. J Clin Endocrinol Metab, 1999, 84, 3648-3655.
14. PARISIEN M, COSMAN F, MORGAN D, SCHNITZER M, LIANG X et al.- Histomorphometric assessment of bone mass, structure and remodeling: a comparison between healthy black and white premanopausal women. J Bone Miner Res, 1997, 12, 948-957.
15. PITCHE P, AFANOU A, AMANGA Y & TCHANGAI-WALLA K - Prévalence des accidents cutanés liés à l'utilisation de cosmétiques dépigmentants chez les femmes à Lomé. Santé, 1997, 7, 161-164.
16. PITCHE P, AFANOU A, AMANGA Y & TCHANGAI-WALLA K - Les pratiques cosmétiques dépigmentantes des femmes à Lomé. Méd Afr Noire, 1998, 45, 709-713.
17. RASMUSON S, OLSSON T & HAGG E - A low dose ACTH test to assess the function of the hypothalamic-pituitary- adrenal axis. Clin Endocrinol, 1996, 44, 151-156.
18. SCARPA A & GUERCI A - Depigmenting procedures and drugs employed by melanoderm populations. J Ethnopharmacol, 1987, 19, 17-66.
19. SYLLA R, DIOUF A, NIANE B, NDIAYE B, GUISSE MB et al.-Pratique de la dépigmentation artificielle de la peau chez les femmes à Dakar et étude analytique des produits dits cosmétiques utilisés. Dakar Méd. 1994, 39, 223-226.
20. TURPEINEN M, MASHKILLEYSON N, BJORKSTEIN F & SALO OP - Percutaneous absorption of hydrocortisone during exacerbation and remission of atopic dematitis in adults. Acta Dermatol Vénéréol, 1998, 68, 331-335.
21. TURPEINEN M, SALO OP & LEISTI S - Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease. Br J Dermatol, 1986, 115, 475-484.
22. WESTER RC, NOONAN PK & MAIBACH HI - Frequency of application on percutaneous absorption of hydrocortisone. Arch Dermatol, 1980, 113, 620-622.
23. WESTER RC, NOONAN PK & MAIBACH HI - Percutaneous absorption of hydrocortisone increases with long-term administration. In vivo study in the rhesus monkey. Arch Dermatol, 1980, 116, 186-188.
24. ZIRKER D, KRUEGER GG & MEIKE AW - Percutaneous absorption of dexamethasone estimated by a plasma radioimmunoassay. J Invest Dermatol, 1976, 66, 376-378.